Cullen/Frost Bankers’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.2K Sell
200
-10
-5% -$75 ﹤0.01% 1297
2025
Q4
$1.51K Buy
210
+10
+5% +$79 ﹤0.01% 1283
2025
Q3
$2.14K Sell
200
-17
-8% -$167 ﹤0.01% 1221
2025
Q2
$2.1K Sell
217
-311
-59% -$3.21K ﹤0.01% 1173
2025
Q1
$7.86K Buy
528
+308
+140% +$4.74K ﹤0.01% 985
2024
Q4
$3.28K Buy
220
+4
+2% +$65 ﹤0.01% 1075
2024
Q3
$4.14K Sell
216
-168
-44% -$3.48K ﹤0.01% 1027
2024
Q2
$7.94K Buy
384
+111
+41% +$2.21K ﹤0.01% 878
2024
Q1
$5.13K Sell
273
-56
-17% -$961 ﹤0.01% 861
2023
Q4
$4.75K Sell
329
-1,478
-82% -$20.1K ﹤0.01% 876
2023
Q3
$31.4K Buy
1,807
+7
+0.4% +$146 ﹤0.01% 808
2023
Q2
$37.5K Sell
1,800
-51
-3% -$1.11K ﹤0.01% 768
2023
Q1
$43.5K Sell
1,851
-39
-2% -$1.05K ﹤0.01% 741
2022
Q4
$52.8K Sell
1,890
-610
-24% -$15.6K ﹤0.01% 690
2022
Q3
$59K Sell
2,500
-1,290
-34% -$38.9K ﹤0.01% 677
2022
Q2
$128K Sell
3,790
-44
-1% -$1.54K ﹤0.01% 568
2022
Q1
$134K Buy
3,834
+112
+3% +$3.83K ﹤0.01% 579
2021
Q4
$113K Sell
3,722
-2,342
-39% -$76.3K ﹤0.01% 624
2021
Q3
$199K Sell
6,064
-2,281
-27% -$73K ﹤0.01% 517
2021
Q2
$253K Buy
+8,345
New +$275K 0.01% 497

Other funds holding OGN

Cullen/Frost Bankers's OGN Position: Q1 2026 in Review

Cullen/Frost Bankers reduced its Organon & Co (OGN) stake by 4.8% in Q1 2026, selling an estimated $75 and leaving 200 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.

Cullen/Frost Bankers first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $253K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Cullen/Frost Bankers held 200 shares of Organon & Co worth $1.2K as of Q1 2026.
  • Cullen/Frost Bankers sold 10 Organon & Co shares in Q1 2026, an estimated $75.
  • Organon & Co made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q1 2026, its #1297 holding.
  • Cullen/Frost Bankers first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Cullen/Frost Bankers's Organon & Co position peaked at $253K in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.